About Us - Intellectual Property
ChromaDex is a licensee of two U.S. patents from the USDA-ARS and the University of Mississippi and is working on the third patent with a strategic partner.
All pterostilbene products developed by ChromaDex, such as pTeroPure, will be based on the technologies licensed from the USDA ARS and the University of Mississippi.
- Patent Pending #1: "Pterostilbene as a New Agonist for the Peroxisome Proliferator-Activated Receptor Alpha Isoform."
- Patent Pending #2: "Method to Ameliorate Oxidative Stress and Improve Working Memory via Pterostilbene Administration."
- Patent Pending #3: "A Key Intermediate for the Preparation of Stilbenes"